The Significance of Thyroid Hormone Transporters in the Brain
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The developing brain is an important target of thyroid hormones. A complex regulatory network involving transfer of thyroid hormones through the brain barriers, interactions between neurons and glial cells, and deiodinase expression, works to deliver the appropriate amount of T3 to the nuclear receptors. The data provided by Heuer et al. (1) in this issue indicates that specific thyroid hormone transporters may also be an essential part of this regulatory system. Thyroid hormones influence brain development from about the end of the first trimester of fetal life. The human fetal brain expresses nuclear T3 receptors at least from the 10th week of gestation, and receptor concentration increases 10-fold during the second trimester in brain and other tissues (2). T4 is present in brain and other tissues, such as liver, kidney, and lung, but T3 is detectable only in brain, at concentrations that result in an occupancy of brain T3 receptors around 25%. The source of T4 reaching the fetal brain up to midgestation is mostly of maternal origin (3). Both T4 and T3 cross the placenta and reach the fetal organs, but only T4 appears to cross the fetal blood-brain barrier. Thus, the administration of T3 by constant infusion to pregnant rat dams increased T3 concentrations in all maternal and fetal tissues except the fetal brain (4). In contrast, the administration of T4 increased T3 content in fetal brain as well as in other tissues. There was also a very important difference between the brain and the rest of the tissues. When increasing amounts of T4 were administered to pregnant dams maintained on methimazole, normal concentrations of T3 in the fetal brain were kept over a much wider range of T4 doses than in other tissues. In adult rats, both T4 and T3 reach the brain from blood, but it was estimated that as much as 80% of the T3 bound to the nuclear receptors was produced locally by type 2 deiodinase (D2) activity (5). As in fetal brain, when either T4 or T3 was administered to hypothyroid rats, the T3 content of the brain was maintained within control values only by T4, but not by T3, infusion (6). Homeostasis of T3 within the brain is maintained within narrow limits by a complex mechanism involving D2 and D3. Several years ago we reported that D2 was predominantly expressed in glial cells of two types, tanycytes and astrocytes (7) (Fig. 1). Tanycytes, in which expression of D2 was also reported by Tu et al. (8), are specialized ependymal cells lining the third ventricle and extending processes to the adjacent hypothalamus and the median eminence. The T3 generated by these cells from cerebrospinal T4 could play a role in TRH-TSH regulation. On the other hand, expression of D2 in the astrocytes suggested to us the existence of interplay between astrocytes and neurons on T3 homeostasis similar to the metabolic coupling between the two cells concerning the glutamate-glutamine cycle or glucose use (9). Astrocytes would produce T3 for neuronal use. As an additional control of neuronal T3 concentration, D3, which degrades T3 to the inactive metabolite diiodothyronine, is expressed in neurons. In this issue, Heuer et al. (1) confirm expression of D2 in the astrocytes and suggest important roles in T3 homeostasis for recently characterized thyroid hormone transporters (Fig. 1). Thyroid hormones are transported through the blood-brain barrier (OATP) or the blood-CSF barrier (OATP and MCT8). In the astrocytes and tanycytes T4 is converted to T3 which then enters the neurons through MCT8. In the neurons both T4 and T3 are degraded by D3. T3 from the tanycytes may reach the portal vessels in the median eminence. Other transporters may be present on the astrocyte or tanycyte membranes. In most cases the transport could be bidirectional, although only one direction is shown. The entry of thyroid hormones into the cells has for a long time been assumed to be by passive diffusion, because thyroid hormones are lipophilic molecules and as such could easily enter the membrane lipid bilayer. Experiments in vivo hardly gave any hint of a saturable process, as was, for example, the binding of T3 to the nucleus, an observation that facilitated the discovery of nuclear receptors. However, in isolated hepatocytes and other cell types, the demonstration of relatively high-affinity sites for both T4 and T3, and the inhibition of cellular uptake by metabolic inhibitors, amino acids, and other chemicals, gave evidence for the physiological significance of thyroid hormone transporters (10). Several molecular entities have been identified as transporters for thyroid hormone (11). They belong to three main families: the organic anion-transporting polypeptides (OATP), the L-amino acid transporters, and the monocarboxylate anion transporters (MCT). Among the many members of the OATP family, human OATP-F (12) and rat Oatp14 (13) are preferentially expressed in brain. The Oatp14 protein is localized in the border of brain capillary endothelial cells a
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic coupling between glia and neurons
Tsacopoulos, M., & Magistretti, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-00877.1996 · Cited by 1,006
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300909200 · Cited by 725 · cited 2×
“MCT8 has been shown to act as a specific transporter for T4 and T3 and displays slightly higher affinity for T3 (14).”
Friesema, E. C., Grueters, A., Biebermann, H., Krude, H., von Moers, A., Reeser, M., Barrett, T. G., Mancilla, E. E., Svensson, J., Kester, M. H., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17226-7 · Cited by 709 · cited 1×
“In vitro uptake of T4 and T3 by fibroblasts isolated from affected males was strongly reduced, and intracellular D2 was increased 6- to 8-fold (17).”
Dumitrescu, A. M., Liao, X.-H., Best, T. B., Brockmann, K., & Refetoff, S. (2004) · The American Journal of Human Genetics · doi:10.1086/380999 · Cited by 706 · cited 1×
“In the postmortem examination of the maternal uncle of one of the patients, also probably affected, loss of neurons in the cerebral cortex, basal ganglia, and cerebellum was found (16).”
Hennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0435 · Cited by 394 · cited 1×
“acids, and other chemicals, gave evidence for the physiological significance of thyroid hormone transporters (10).”
The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain
Guadaño-Ferraz, A., Obregón, M. J., Germain, D. L. S., & Bernal, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10391 · Cited by 372 · cited 1×
“Several years ago we reported that D2 was predominantly expressed in glial cells of two types, tanycytes and astrocytes (7) (Fig.”
Self-citationCRANTZ, F. R., SILVA, J. E., & LARSEN, P. R. (1982) · Endocrinology · doi:10.1210/endo-110-2-367 · Cited by 340
Tu, H. M., Kim, S.-W., Salvatore, D., Bartha, T., Legradi, G., Larsen, P. R., & Lechan, R. M. (1997) · Endocrinology · doi:10.1210/endo.138.8.5318 · Cited by 302
Sugiyama, D., Kusuhara, H., Taniguchi, H., Ishikawa, S., Nozaki, Y., Aburatani, H., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306933200 · Cited by 283
Heuer, H., Maier, M. K., Iden, S., Mittag, J., Friesema, E. C. H., Visser, T. J., & Bauer, K. (2005) · Endocrinology · doi:10.1210/en.2004-1179 · Cited by 269 · cited 2×
“(1) confirm expression of D2 in the astrocytes and suggest important roles in T3 homeostasis for recently characterized thyroid hormone transporters (Fig.”
Cited by
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Influence of maternal thyroid hormones during gestation on fetal brain development
Moog, N. K., Entringer, S., Heim, C., Wadhwa, P. D., Kathmann, N., & Buss, C. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.070 · Cited by 474
Thyroid Hormones and Brain Development
Bernal, J. (2005) · Vitamins & Hormones · doi:10.1016/s0083-6729(05)71004-9 · Cited by 471
Self-citationParadigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10
Friesema, E. C. H., Jansen, J., Jachtenberg, J.-W., Visser, W. E., Kester, M. H. A., & Visser, T. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0112 · Cited by 285
Wirth, E. K., Roth, S., Blechschmidt, C., Hölter, S. M., Becker, L., Racz, I., Zimmer, A., Klopstock, T., Gailus-Durner, V., Fuchs, H., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6055-08.2009 · Cited by 193
Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain
Mayerl, S., Visser, T. J., Darras, V. M., Horn, S., & Heuer, H. (2012) · Endocrinology · doi:10.1210/en.2011-1633 · Cited by 138
Chang, S.-C., Ehresman, D. J., Bjork, J. A., Wallace, K. B., Parker, G. A., Stump, D. G., & Butenhoff, J. L. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.01.005 · Cited by 118
Metadata
- Authors
- Bernal, J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-04-01
- Volume
- 146
- Issue
- 4
- Pages
- 1698-1700
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2136488101
- Cited by
- 65
- References
- 11
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.